In systemic sclerosis (SSc), interstitial lung disease (ILD) is common (>80%) and worsens the prognosis of the disease, but severe progressive damage develops only in 8–10% of cases. Interstitial changes in the lungs occur early (within the first 3–5 years of the disease). The histological manifestations are similar to those of idiopathic ILD.The main tool for screening and diagnosing of ILD associated with SSc is high-resolution computed tomography of the lungs, resulting data influence the choice of therapy. In most patients a relatively intact and stable forced vital capacity of the lungs is recorded for a long time, but the diffusion capacity of the lungs decreases early and steadily. Pulmonary functional tests have prognostic value....
Interstitial lung disease (ILD) affects about 90% of patients with systemic sclerosis (SSc). It is a...
Interstitial lung disease (ILD) is a debilitating complication of systemic sclerosis (SSc) and now t...
SummaryInterstitial lung disease (ILD) is a common manifestation of systemic sclerosis (SSc) mainly ...
Abstract Background Systemic sclerosis (SSc) is a rare connective tissue disease with a heterogeneou...
Interstitial lung disease (ILD) is common in systemic sclerosis (SSc) patients and despite recent ad...
Interstitial lung disease (ILD) is common in systemic sclerosis (SSc) patients and despite recent ad...
The involvement of the lungs in systemic sclerosis (SSc) is one of the most frequent organ manifesta...
Interstitial lung disease (ILD) is common in systemic sclerosis (SSc) patients and despite recent ad...
Systemic sclerosis (SSc) has the highest fatality rate among connective tissue diseases and is chara...
Interstitial lung disease is an early and serious complication of systemic sclerosis (SSc). Because ...
Systemic sclerosis (SSc) has the highest fatality rate among connective tissue diseases and is chara...
Systemic sclerosis (SSc) has the highest fatality rate among connective tissue diseases and is chara...
Systemic sclerosis (SSc) has the highest fatality rate among connective tissue diseases and is chara...
Systemic sclerosis (SSc) has the highest fatality rate among connective tissue diseases and is chara...
Interstitial lung disease (ILD) affects about 90% of patients with systemic sclerosis (SSc). It is a...
Interstitial lung disease (ILD) affects about 90% of patients with systemic sclerosis (SSc). It is a...
Interstitial lung disease (ILD) is a debilitating complication of systemic sclerosis (SSc) and now t...
SummaryInterstitial lung disease (ILD) is a common manifestation of systemic sclerosis (SSc) mainly ...
Abstract Background Systemic sclerosis (SSc) is a rare connective tissue disease with a heterogeneou...
Interstitial lung disease (ILD) is common in systemic sclerosis (SSc) patients and despite recent ad...
Interstitial lung disease (ILD) is common in systemic sclerosis (SSc) patients and despite recent ad...
The involvement of the lungs in systemic sclerosis (SSc) is one of the most frequent organ manifesta...
Interstitial lung disease (ILD) is common in systemic sclerosis (SSc) patients and despite recent ad...
Systemic sclerosis (SSc) has the highest fatality rate among connective tissue diseases and is chara...
Interstitial lung disease is an early and serious complication of systemic sclerosis (SSc). Because ...
Systemic sclerosis (SSc) has the highest fatality rate among connective tissue diseases and is chara...
Systemic sclerosis (SSc) has the highest fatality rate among connective tissue diseases and is chara...
Systemic sclerosis (SSc) has the highest fatality rate among connective tissue diseases and is chara...
Systemic sclerosis (SSc) has the highest fatality rate among connective tissue diseases and is chara...
Interstitial lung disease (ILD) affects about 90% of patients with systemic sclerosis (SSc). It is a...
Interstitial lung disease (ILD) affects about 90% of patients with systemic sclerosis (SSc). It is a...
Interstitial lung disease (ILD) is a debilitating complication of systemic sclerosis (SSc) and now t...
SummaryInterstitial lung disease (ILD) is a common manifestation of systemic sclerosis (SSc) mainly ...